Photo - Modality.AI, Inc.
43043

Modality.AI, Inc.

Optimize drug trials through multimodal AI

USA, California
Market: Medicine, Pharmacology, Artificial Intelligence
Stage of the project: Operating business

Date of last change: 03.04.2020
Min investment
$  100.000
Show contacts
Total required
$ 2.000.000
Rating
equalizer из 1000
help
Calculated and estimated occupancy of the project (more about ratings)
My rating
1
2
3
4
5
6
7
8
9
10
Average rating:

Idea

Modality's Neurological Lab Test makes clinical trials faster, reduces failures, and increases the ROI of drugs. It uses multimodal AI to produce accurate metrics of facial and speech behaviors, that are predictive of the target disease.

Current Status

The Neurological Lab Test is in production. It is being used at multiple renowned institutions in IRB-approved clinical trials and drug trials, e.g. at:
* UCSF, San Francisco, CA
* UT Dallas, Dallas, TX
* UT Austin, Austin, TX
* Retrotope, Inc., Los Altos, CA
There are many more institution various stages of preparation (IRB approval pending, LOIs, pilots), e.g.
* Massachusetts General Hospital, Boston, MA
* Verge Genomics, South San Francisco, CA
* AcuraStem, Monrovia, CA
* LEO Pharma, Copenhagen, DK
* Purdue University, West Lafayette, IN
5,00
1
2
3
4
5
1 voice
Sign in/Sign up
arrow_back
EN
more_horiz
close
visibility334
star0
Add to favorites
Delete from favorites
share
close
thumb_up1
Like
Unlike
Idea
Current Status
Market
Problem or Opportunity
Solution (product or service)
Competitors
Advantages or differentiators
Finance
Invested in previous rounds, $
Business model
Money will be spent on
Offer for investor
Team or Management
Mentors & Advisors
Lead investor
Risks
Incubation/Acceleration programs accomplishment
Won the competition and other awards
Invention/Patent
Photos
Product Video